Report cover image

North America Iron-Deficiency Anemia Therapy Market

Publisher Data Bridge Market Research
Published Jul 01, 2024
Length 165 Pages
SKU # DAABD19176132

Description

North America Iron-Deficiency Anemia Therapy Market


The North America iron-deficiency anemia therapy market is expected to reach USD 4.22 billion by 2031 from USD 2.04 billion in 2023, growing with a CAGR of 9.9% in the forecast period of 2024 to 2031.

Market Segmentation:
North America Iron-Deficiency Anemia Therapy Market, By Therapy (Parenteral Iron Therapy and Oral Iron Therapy), Therapy Area (Obstetrics and Gynecology, Renal Diseases, Congestive Heart Failure (CHF), Oncology, Inflammatory Bowel Disease, and Others), Population (Adults, Geriatric, and Pediatric), End User (Hospitals, Specialty Clinics, Home Care Setting, and Others), Distribution Channel (Hospital Pharmacy, Drug Stores and Retail Pharmacies, and Online Pharmacies), Countries (Mexico, Canada, and U.S.) - Industry Trends and Forecast to 2031

Overview of North America Iron-Deficiency Anemia Therapy Market Dynamics:

Driver
• Rising incidences of iron deficiency anemia
Restrain

• Stringent regulations for iron deficiency anemia therapy

Opportunity

• Increasing research and development activities

Market Players:

The key market players operating in the North America iron-deficiency anemia therapy market are listed below:

• Vifor Pharma Ltd. (Europe)
• DAIICHI SANKYO COMPANY, LIMITED (Japan)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• Fresenius Kabi AG (Germany)
• PHARMACOSMOS A/S (Europe)
• Thorne (U.S.)
• Lupin (India)
• Blackmores (Australia)
• Shield Therapeutics plc (UK)
• Aspen Pharmacare Australia Pty Ltd. (Australia)
• AFT Pharmaceuticals (New Zealand)
• Alkem (India)
• Akebia Therapeutics, Inc. (U.S.)
• Farlex (India)
• GSK plc. (UK)
• Novartis AG (Switzerland)
• Orion Corporation (Europe)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Viatris Inc. (U.S.)
• Zydus (India)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. This publisher does offer titles that are created upon receipt of order.

Table of Contents

165 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Iron-deficiency Anemia Therapy Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market End User Coverage Grid
2.8 Product Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Secondary Sources
2.11 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestal Analysis
4.2 Porter’s Five Forces
5 Market Overview
5.1 Drivers
5.1.1 Rising Incidences Of Iron Deficiency Anemia
5.1.2 Introduction Of Novel Drugs In The Market
5.1.3 Inclination Towards Social Healthcare On Women Health Specifically Anemia
5.2 Restraints
5.2.1 Stringent Regulations For Iron Deficiency Anemia Therapy
5.2.2 Availability Of Alternative Treatment Options
5.2.3 High Cost Of Therapy
5.3 Opportunities
5.3.1 Increasing Research And Development Activities
5.3.2 Enhancing Drug Quality And Reimbursement Policies
5.3.3 Strategic Acquisitions And Mergers
5.4 Challenges
5.4.1 Limitation In Diagnosing Iron Deficiency Anemia In Inflammatory Conditions
5.4.2 Emerging Drug Resistance
6 North America Iron-deficiency Anemia Therapy Market, By Therapy
6.1 Overview
6.2 Parenteral Iron Therapy
6.3 Oral Iron Therapy
7 North America Iron-deficiency Anemia Therapy Market, By Therapy Area
7.1 Overview
7.2 Obstetrics And Gynecology
7.3 Renal Diseases
7.4 Congestive Heart Failure (Chf)
7.5 Oncology
7.6 Inflammatory Bowel Disease
7.7 Others
8 North America Iron-deficiency Anemia Therapy Market, By Population
8.1 Overview
8.2 Adults
8.3 Geriatric
8.4 Pediatric
9 North America Hospitals In Iron-deficiency Anemia Therapy Market, By End User
9.1 Overview
9.2 Hospitals
9.3 Specialty Clinics
9.4 Home Care Setting
9.5 Others
10 North America Dengue Treatment Market, By Distribution Channel
10.1 Overview
10.2 Hospital Pharmacy
10.3 Drug Stores And Retail Pharmacies
10.4 Online Pharmacies
11 North America Iron-deficiency Anemia Therapy Market, By Region
11.1 North America
11.1.1 Mexico
11.1.2 Canada
11.1.3 U.S.
12 North America Iron-deficiency Anemia Therapy Market: Company Landscape
12.1 Company Share Analysis: North America
13 Swot Analysis
14 Company Profile
14.1 Vifor Pharma Ltd.
14.1.1 Company Snapshot
14.1.2 Revenue Analysis
14.1.3 Company Share Analysis
14.1.4 Product Portfolio
14.1.5 Recent Development
14.2 Daiichi Sankyo Company, Limited.
14.2.1 Company Snapshot
14.2.2 Company Share Analysis
14.2.3 Product/ Service Portfolio
14.2.4 Recent Development
14.3 Aft Pharmaceuticals
14.3.1 Company Snapshot
14.3.2 Revenue Analysis
14.3.3 Product/ Service Portfolio
14.3.4 Recent Development
14.4 Sanofi
14.4.1 Company Snapshot
14.4.2 Revenue Analysis
14.4.3 Company Share Analysis
14.4.4 Product Portfolio
14.4.5 Recent Development
14.5 Pfizer Inc.
14.5.1 Company Snapshot
14.5.2 Revenue Analysis
14.5.3 Company Share Analysis
14.5.4 Product Portfolio
14.5.5 Recent Development
14.6 Akebia Therapeutics, Inc
14.6.1 Company Snapshot
14.6.2 Revenue Analysis
14.6.3 Product Portfolio
14.6.4 Recent Development
14.7 Alkem.
14.7.1 Company Snapshot
14.7.2 Revenue Analysis
14.7.3 Product Portfolio
14.7.4 Recent Development
14.8 Aspen Pharmacare Australia Pty Ltd.
14.8.1 Company Snapshot
14.8.2 Product/ Service Portfolio
14.8.3 Recent Development
14.9 Blackmores
14.9.1 Company Snapshot
14.9.2 Revenue Analysis
14.9.3 Product/ Service Portfolio
14.9.4 Recent Development
14.10 Farlex
14.10.1 Company Snapshot
14.10.2 Product Portfolio
14.10.3 Recent Development
14.11 Fresenius Kabi Ag
14.11.1 Company Snapshot
14.11.2 Revenue Analysis
14.11.3 Product Portfolio
14.11.4 Recent Developments
14.12 Glaxosmithkline Plc.
14.12.1 Company Snapshot
14.12.2 Revenue Analysis
14.12.3 Product Portfolio
14.12.4 Recent Developments
14.13 Lupin
14.13.1 Company Snapshot
14.13.2 Revenue Analysis
14.13.3 Product Portfolio
14.13.4 Recent Development
14.14 Novartis Ag
14.14.1 Company Snapshot
14.14.2 Revenue Analysis
14.14.3 Product Portfolio
14.14.4 Recent Development
14.15 Orion Corporation
14.15.1 Company Snapshot
14.15.2 Revenue Analysis
14.15.3 Product Portfolio
14.15.4 Recent Development
14.16 Pharmacosmos A/S
14.16.1 Company Snapshot
14.16.2 Product Portfolio
14.16.3 Recent Development
14.17 Shield Therapeutics Plc
14.17.1 Company Snapshot
14.17.2 Revenue Analysis
14.17.3 Product Portfolio
14.17.4 Recent Development
14.18 Teva Pharmaceutical Industries Ltd.
14.18.1 Company Snapshot
14.18.2 Revenue Analysis
14.18.3 Product Portfolio
14.18.4 Recent Development
14.19 Cothorne
14.19.1 Company Snapshot
14.19.2 Product/ Service Portfolio
14.19.3 Recent Development
14.20 Viatris Inc.
14.20.1 Company Snapshot
14.20.2 Revenue Analysis
14.20.3 Product Portfolio
14.20.4 Recent Developments
14.21 Zydus Group
14.21.1 Company Snapshot
14.21.2 Revenue Analysis
14.21.3 Product Portfolio
14.21.4 Recent Development
15 Questionnaire
16 Related Reports
Table 1 Prevalence Of Anemia In Children Of Africa And Asia
Table 2 Iron Deficiency Anemia Therapeutics R&D Activities
Table 3 Causes, Prevalence, And Clinical Consequences Of Iron Deficiency In Inflammatory Conditions
Table 4 North America Iron-deficiency Anemia Therapy Market, By Therapy, 2022-2031 (Usd Million)
Table 5 North America Parenteral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 6 North America Parenteral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Type, 2022-2031 (Usd Million)
Table 7 North America Oral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 8 North America Oral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Type, 2022-2031 (Usd Million)
Table 9 North America Iron-deficiency Anemia Therapy Market, By Therapy Area, 2022-2031 (Usd Million)
Table 10 North America Obstetrics And Gynecology In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 11 North America Renal Diseases In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 12 North America Congestive Heart Failure (Chf) In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 13 North America Oncology In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 14 North America Inflammatory Bowel Disease In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 15 North America Others In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 16 North America Iron-deficiency Anemia Therapy Market, By Population, 2022-2031 (Usd Million)
Table 17 North America Adults In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 18 North America Geriatric In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 19 North America Pediatric In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 20 North America Iron-deficiency Anemia Therapy Market, By End User, 2022-2031 (Usd Million)
Table 21 North America Hospitals In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 22 North America Hospitals In Iron-deficiency Anemia Therapy Market, By End User, 2022-2031 (Usd Million)
Table 23 North America Specialty Clinics In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 24 North America Home Care Setting In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 25 North America Others In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 26 North America Iron-deficiency Anemia Therapy Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 27 North America Hospital Pharmacy In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 28 North America Drug Stores And Retail Pharmacies In Iron-deficiency Anemia Therapy Market, By Region, 2022-2031 (Usd Million)
Table 29 North America Online Pharmacies In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 30 North America Iron-deficiency Anemia Therapy Market, By Country, 2022-2031 (Usd Million)
Table 31 North America Iron-deficiency Anemia Therapy Market, By Therapy, 2022-2031 (Usd Million)
Table 32 North America Parenteral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Type, 2022-2031 (Usd Million)
Table 33 North America Oral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Type, 2022-2031 (Usd Million)
Table 34 North America Iron-deficiency Anemia Therapy Market, By Therapy Area, 2022-2031 (Usd Million)
Table 35 North America Iron-deficiency Anemia Therapy Market, By Population, 2022-2031 (Usd Million)
Table 36 North America Iron-deficiency Anemia Therapy Market, By End User, 2022-2031 (Usd Million)
Table 37 North America Hospitals In Iron-deficiency Anemia Therapy Market, By End User, 2022-2031 (Usd Million)
Table 38 North America Iron-deficiency Anemia Therapy Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 39 Mexico Iron-deficiency Anemia Therapy Market, By Therapy, 2022-2031 (Usd Million)
Table 40 Mexico Parenteral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Type, 2022-2031 (Usd Million)
Table 41 Mexico Oral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Type, 2022-2031 (Usd Million)
Table 42 Mexico Iron-deficiency Anemia Therapy Market, By Therapy Area, 2022-2031 (Usd Million)
Table 43 Mexico Iron-deficiency Anemia Therapy Market, By Population, 2022-2031 (Usd Million)
Table 44 Mexico Iron-deficiency Anemia Therapy Market, By End User, 2022-2031 (Usd Million)
Table 45 Mexico Hospitals In Iron-deficiency Anemia Therapy Market, By End User, 2022-2031 (Usd Million)
Table 46 Mexico Iron-deficiency Anemia Therapy Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 47 Canada Iron-deficiency Anemia Therapy Market, By Therapy, 2022-2031 (Usd Million)
Table 48 Canada Parenteral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Type, 2022-2031 (Usd Million)
Table 49 Canada Oral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Type, 2022-2031 (Usd Million)
Table 50 Canada Iron-deficiency Anemia Therapy Market, By Therapy Area, 2022-2031 (Usd Million)
Table 51 Canada Iron-deficiency Anemia Therapy Market, By Population, 2022-2031 (Usd Million)
Table 52 Canada Iron-deficiency Anemia Therapy Market, By End User, 2022-2031 (Usd Million)
Table 53 Canada Hospitals In Iron-deficiency Anemia Therapy Market, By End User, 2022-2031 (Usd Million)
Table 54 Canada Iron-deficiency Anemia Therapy Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 55 U.S. Iron-deficiency Anemia Therapy Market, By Therapy, 2022-2031 (Usd Million)
Table 56 U.S. Parenteral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Type, 2022-2031 (Usd Million)
Table 57 U.S. Oral Iron Therapy In Iron-deficiency Anemia Therapy Market, By Type, 2022-2031 (Usd Million)
Table 58 U.S. Iron-deficiency Anemia Therapy Market, By Therapy Area, 2022-2031 (Usd Million)
Table 59 U.S. Iron-deficiency Anemia Therapy Market, By Population, 2022-2031 (Usd Million)
Table 60 U.S. Iron-deficiency Anemia Therapy Market, By End User, 2022-2031 (Usd Million)
Table 61 U.S. Hospitals In Iron-deficiency Anemia Therapy Market, By End User, 2022-2031 (Usd Million)
Table 62 U.S. Iron-deficiency Anemia Therapy Market, By Distribution Channel, 2022-2031 (Usd Million)
Figure 1 North America Iron-deficiency Anemia Therapy Market: Segmentation
Figure 2 North America Iron-deficiency Anemia Therapy Market: Data Triangulation
Figure 3 North America Iron-deficiency Anemia Therapy Market: Droc Analysis
Figure 4 North America Iron-deficiency Anemia Therapy Market: North America Vs Regional Market Analysis
Figure 5 North America Iron-deficiency Anemia Therapy Market: Company Research Analysis
Figure 6 North America Iron-deficiency Anemia Therapy Market: Interview Demographics
Figure 7 North America Iron-deficiency Anemia Therapy Market: End User Coverage Grid
Figure 8 North America Iron-deficiency Anemia Therapy Market: Dbmr Market Position Grid
Figure 9 North America Iron-deficiency Anemia Therapy Market: Segmentation
Figure 10 North America Iron-deficiency Anemia Therapy Market: Strategic Decisions
Figure 11 North America Iron-deficiency Anemia Therapy Market: Segmentation Two Segments Comprise
Figure 12 North America Iron-deficiency Anemia Therapy Market: Executive Summary
Figure 13 Rising Incidences Of Iron Deficiency Anemia Are Driving The Growth Of The North America Iron-deficiency Anemia Therapy Market From 2024 To 2031
Figure 14 The Therapy Segment Is Expected To Account For The Largest Share Of The North America Iron-deficiency Anemia Therapy Market In 2024 And 2031
Figure 15 Drivers, Restraint, Opportunities And Challenge Of North America Iron-deficiency Anemia Therapy Market
Figure 16 North America Iron-deficiency Anemia Therapy Market: By Therapy, 2023
Figure 17 North America Iron-deficiency Anemia Therapy Market: By Therapy, 2024-2031 (Usd Million)
Figure 18 North America Iron-deficiency Anemia Therapy Market: By Therapy, Cagr (2024-2031)
Figure 19 North America Iron-deficiency Anemia Therapy Market: By Therapy, Lifeline Curve
Figure 20 North America Iron-deficiency Anemia Therapy Market: By Therapy Area, 2023
Figure 21 North America Iron-deficiency Anemia Therapy Market: By Therapy Area, 2024-2031 (Usd Million)
Figure 22 North America Iron-deficiency Anemia Therapy Market: By Therapy Area, Cagr (2024-2031)
Figure 23 North America Iron-deficiency Anemia Therapy Market: By Therapy Area, Lifeline Curve
Figure 24 North America Iron-deficiency Anemia Therapy Market: By Population, 2023
Figure 25 North America Iron-deficiency Anemia Therapy Market: By Population, 2024-2031 (Usd Million)
Figure 26 North America Iron-deficiency Anemia Therapy Market: By Population, Cagr (2024-2031)
Figure 27 North America Iron-deficiency Anemia Therapy Market: By Population, Lifeline Curve
Figure 28 North America Iron-deficiency Anemia Therapy Market: By End User, 2023
Figure 29 North America Iron-deficiency Anemia Therapy Market: By End User, 2024-2031 (Usd Million)
Figure 30 North America Iron-deficiency Anemia Therapy Market: By End User, Cagr (2024-2031)
Figure 31 North America Iron-deficiency Anemia Therapy Market: By End User, Lifeline Curve
Figure 32 North America Iron-deficiency Anemia Therapy Market: By Distribution Channel, 2023
Figure 33 North America Iron-deficiency Anemia Therapy Market: By Distribution Channel, 2024-2031 (Usd Million)
Figure 34 North America Iron-deficiency Anemia Therapy Market: By Distribution Channel, Cagr (2024-2031)
Figure 35 North America Iron-deficiency Anemia Therapy Market: By Distribution Channel, Lifeline Curve
Figure 36 North America Iron-deficiency Anemia Therapy Market: Snapshot (2023)
Figure 37 North America Iron-deficiency Anemia Therapy Market: Company Share 2023 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us